|
83
|
289
|
4i93A |
Structure of the bsk8 kinase domain (semet labeled) |
|
72
|
273
|
4id7A |
Ack1 kinase in complex with the inhibitor cis-3-[8-amino-1-(4-phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol |
|
75
|
287
|
4ithA |
Crystal structure of rip1 kinase in complex with necrostatin-1 analog |
|
85
|
265
|
4jbpA |
Novel aurora kinase inhibitors reveal mechanisms of hurp in nucleation of centrosomal and kinetochore microtubules |
|
91
|
296
|
4i3zA |
Structure of pcdk2/cyclina bound to adp and 2 magnesium ions |
|
94
|
336
|
4ijpA |
Crystal structure of human prpf4b kinase domain in complex with 4-{5-[(2-chloro-pyridin-4-ylmethyl)-carbamoyl]-thiophen-2-yl}-benzo[b]thiophene-2-carboxylic acid amine |
|
76
|
266
|
4j8mA |
Aurora a in complex with cd532 |
|
99
|
301
|
4ibmA |
Crystal structure of insulin receptor kinase domain in complex with an inhibitor irfin-1 |
|
85
|
293
|
4j53A |
Crystal structure of plk1 in complex with tak-960 |
|
82
|
287
|
4i20A |
Crystal structure of monomeric (v948r) primary oncogenic mutant l858r egfr kinase domain |
|
96
|
348
|
4j1rA |
Crystal structure of gsk3b in complex with inhibitor 15r |
|
80
|
300
|
4jg8A |
Structure of rsk2 t493m ctd mutant bound to 2-cyano-n-(1-hydroxy-2-methylpropan-2-yl)-3-(3-(3,4,5-trimethoxyphenyl)-1h-indazol-5-yl)acrylamide |
|
97
|
354
|
4hyuA |
Crystal structure of jnk1 in complex with jip1 peptide and 4-{4-[4-(3-methanesulfonyl-propoxy)-indazol-1-yl]-pyrimidin-2-ylamino}-cyclohexan |
|
74
|
273
|
4iaaA |
Crystal structure of ser/thr kinase pim1 in complex with thioridazine |
|
104
|
346
|
4ix5A |
Crystal structure of a stt7 homolog from micromonas algae in complex with amp-pnp |
|
82
|
266
|
4jbqA |
Novel aurora kinase inhibitors reveal mechanisms of hurp in nucleation of centrosomal and kinetochore microtubules |
|
108
|
336
|
4iafA |
Room temperature x-ray structure of camp dependent protein kinase a in complex with high mg2+ concentration, adp and phosphorylated peptide psp20 |
|
81
|
265
|
4jajA |
Crystal structure of aurora kinase a in complex with benzo[c][1,8]naphthyridin-6(5h)-one |
|
189
|
659
|
4iwqA |
Crystal structure and mechanism of activation of tbk1 |
|
86
|
290
|
4i5cA |
The jak1 kinase domain in complex with inhibitor |
|
136
|
463
|
4ih8A |
Crystal structure of tgcdpk1 with inhibitor bound |
|
100
|
355
|
4ic7A |
Crystal structure of the erk5 kinase domain in complex with an mkk5 binding fragment |
|
85
|
273
|
4i4eA |
Structure of focal adhesion kinase catalytic domain in complex with hinge binding pyrazolobenzothiazine compound. |
|
105
|
347
|
4iz5A |
Structure of the complex between erk2 phosphomimetic mutant and pea-15 |
|
98
|
297
|
4jjrA |
A p21 crystal form of mammalian casein kinase 1 delta |
|
110
|
331
|
4ib5A |
Structure of human protein kinase ck2 catalytic subunit in complex with a ck2beta-competitive cyclic peptide |
|
106
|
346
|
4ix6A |
Crystal structure of a stt7 homolog from micromonas algae soaked with atp |
|
86
|
309
|
4jg7A |
Structure of rsk2 ctd bound to 3-(3-(1h-pyrrolo[2,3-b]pyridine-3-carbonyl)phenyl)-2-cyanoacrylamide |
|
86
|
302
|
4ivdA |
Jak1 kinase (jh1 domain) in complex with compound 34 |
|
82
|
277
|
4k18A |
Structure of pim-1 kinase bound to 5-(4-cyanobenzyl)-n-(4-fluorophenyl)-7-hydroxypyrazolo[1,5-a]pyrimidine-3-carboxamide |
|
111
|
336
|
4iacA |
X-ray structure of camp dependent protein kinase a in complex with high mg2+ concentration, amp-pcp and pseudo-substrate peptide sp20 |
|
130
|
369
|
4jqeA |
Crystal structure of scck2 alpha in complex with amppn |
|
71
|
266
|
4j8nA |
Aurora a kinase apo |
|
91
|
297
|
4j97A |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic gain-of-function k659e mutation identified in endometrial cancer. |
|
86
|
324
|
4i23A |
Crystal structure of the wild-type egfr kinase domain in complex with dacomitinib (soaked) |
|
95
|
354
|
4izyA |
Crystal structure of jnk1 in complex with jip1 peptide and 4-{4-[4-(4-methanesulfonyl-piperidin-1-yl)-indol-1-yl]-pyrimidin-2-ylamino}-cyclohexan |
|
73
|
273
|
4i41A |
Crystal structure of human ser/thr kinase pim1 in complex with mitoxantrone |
|
95
|
354
|
4hysA |
Crystal structure of jnk1 in complex with jip1 peptide and 4-(4-indazol-1-yl-pyrimidin-2-ylamino)-cyclohexan |
|
93
|
290
|
4jdkA |
Crystal structure of serine/threonine-protein kinase pak 4 f461v mutant in complex with paktide s peptide substrate |
|
101
|
348
|
4i5hA |
Crystal structure of a double mutant rat erk2 complexed with a type ii quinazoline inhibitor |
|
67
|
264
|
4jxfA |
Crystal structure of plk4 kinase with an inhibitor: 400631 ((1r,2s)-2-{3-[(e)-2-{4-[(dimethylamino)methyl]phenyl}ethenyl]-2h-indazol-6-yl}-5'-methoxyspiro[cyclopropane-1,3'-indol]-2'(1'h)-one) |
|
91
|
288
|
4i6qA |
Jak3 kinase domain in complex with 2-phenoxy-5h-pyrrolo[2,3-b]pyrazine-7-carboxylic acid ((s)-1-cyclopropyl-ethyl)-amide |
|
90
|
323
|
4imyA |
The aff4 scaffold binds human p-tefb adjacent to hiv tat |
|
88
|
299
|
4j99A |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the gain-of-function k659t mutation. |
|
83
|
229
|
4i6lA |
Crystal structure of otub1 in complex with ubiquitin variant |
|
86
|
324
|
4jrvA |
Crystal structure of egfr kinase domain in complex with compound 4c |
|
92
|
315
|
4i24A |
Structure of t790m egfr kinase domain co-crystallized with dacomitinib |
|
107
|
343
|
4idtA |
Crystal structure of nik with 11-bromo-5,6,7,8-tetrahydropyrimido[4',5':3,4]cyclohepta[1,2-b]indol-2-amine (t28) |
|
100
|
320
|
4jnwA |
Bacterially expressed titin kinase |
|
100
|
330
|
4ianA |
Crystal structure of apo human prpf4b kinase domain |
